Skip to main content
Top
Published in: Langenbeck's Archives of Surgery 3/2020

01-05-2020 | Computed Tomography | Systematic Reviews and Meta-analyses

Effect of time to surgery in resectable pancreatic cancer: a systematic review and meta-analysis

Authors: Philip C. Müller, James Hodson, Christoph Kuemmerli, Marit Kalisvaart, Rupaly Pande, Keith J. Roberts

Published in: Langenbeck's Archives of Surgery | Issue 3/2020

Login to get access

Abstract

Purpose

Achieving surgical resection is essential if patients with pancreatic ductal adenocarcinoma (PDAC) have a chance for cure. The objective of this study was to evaluate the effect of time to surgery on resection rates in patients with resectable PDAC.

Methods

A systematic literature search was performed to identify studies reporting times to surgery and resection rates. Meta-regression models were then produced to assess the relationship between time to surgery and resection rates, using both intra- and inter-study comparisons.

Results

A total of 21 studies were included, comprising n = 2171 patients, with a pooled resection rate of 76%. Intra-study meta-analysis of the five studies that reported comparisons between patients with vs. without preoperative biliary drainage (PBD) or with long vs. short delays to surgery found earlier surgery to be associated with a significantly higher rate of resection (pooled odds ratio 1.93, 95% CI: 1.25–2.97, P = 0.003). Inter-study meta-regression across all studies found a tendency for resection rates to decline with increasing time from CT or ERCP to surgery (gradient − 0.13 log-odds per week, 95% CI − 0.28, 0.03, P = 0.100), although this did not reach statistical significance, in part due to considerable heterogeneity between studies.

Conclusion

Pathways to reduce the time to surgery, primarily by avoiding PBD, demonstrate significantly greater resection rates. Early surgery, including avoidance of PBD, not only provides patients with the benefit of avoiding harm associated with PBD but also with a greater chance of undergoing resection.
Appendix
Available only for authorised users
Literature
2.
go back to reference Fujioka S, Misawa T, Okamoto T, Gocho T, Futagawa Y, Ishida Y, Yanaga K (2007) Preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for the evaluation of curability and resectability in patients with pancreatic adenocarcinoma. J Hepatobiliary Pancreat Surg 14:539–544. https://doi.org/10.1007/s00534-006-1184-3 CrossRefPubMed Fujioka S, Misawa T, Okamoto T, Gocho T, Futagawa Y, Ishida Y, Yanaga K (2007) Preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for the evaluation of curability and resectability in patients with pancreatic adenocarcinoma. J Hepatobiliary Pancreat Surg 14:539–544. https://​doi.​org/​10.​1007/​s00534-006-1184-3 CrossRefPubMed
6.
go back to reference Kneuertz PJ, Cunningham SC, Cameron JL, Torrez S, Tapazoglou N, Herman JM, Makary MA, Eckhauser F, Wang J, Hirose K, Edil BH, Choti MA, Schulick RD, Wolfgang CL, Pawlik TM (2011) Palliative surgical management of patients with unresectable pancreatic adenocarcinoma: trends and lessons learned from a large, single institution experience. J Gastrointest Surg Off J Soc Surg Aliment Tract 15:1917–1927. https://doi.org/10.1007/s11605-011-1665-9 CrossRef Kneuertz PJ, Cunningham SC, Cameron JL, Torrez S, Tapazoglou N, Herman JM, Makary MA, Eckhauser F, Wang J, Hirose K, Edil BH, Choti MA, Schulick RD, Wolfgang CL, Pawlik TM (2011) Palliative surgical management of patients with unresectable pancreatic adenocarcinoma: trends and lessons learned from a large, single institution experience. J Gastrointest Surg Off J Soc Surg Aliment Tract 15:1917–1927. https://​doi.​org/​10.​1007/​s11605-011-1665-9 CrossRef
7.
go back to reference Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA, the PRISMA-P Group (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 349:g7647CrossRef Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA, the PRISMA-P Group (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 349:g7647CrossRef
11.
go back to reference Eshuis WJ, van der Gaag NA, Rauws EAJ, van Eijck CHJ, Bruno MJ, Kuipers EJ, Coene PP, Kubben FJGM, Gerritsen JJGM, Greve JW, Gerhards MF, de Hingh IHJT, Klinkenbijl JH, Nio CY, de Castro SMM, Busch ORC, van Gulik TM, Bossuyt PMM, Gouma DJ (2010) Therapeutic delay and survival after surgery for cancer of the pancreatic head with or without preoperative biliary drainage. Ann Surg 252:840–849. https://doi.org/10.1097/SLA.0b013e3181fd36a2 CrossRefPubMed Eshuis WJ, van der Gaag NA, Rauws EAJ, van Eijck CHJ, Bruno MJ, Kuipers EJ, Coene PP, Kubben FJGM, Gerritsen JJGM, Greve JW, Gerhards MF, de Hingh IHJT, Klinkenbijl JH, Nio CY, de Castro SMM, Busch ORC, van Gulik TM, Bossuyt PMM, Gouma DJ (2010) Therapeutic delay and survival after surgery for cancer of the pancreatic head with or without preoperative biliary drainage. Ann Surg 252:840–849. https://​doi.​org/​10.​1097/​SLA.​0b013e3181fd36a2​ CrossRefPubMed
13.
go back to reference Ong SL, Garcea G, Thomasset SC, Mann CD, Neal CP, Abu Amara M, Dennison AR, Berry DP (2008) Surrogate markers of resectability in patients undergoing exploration of potentially resectable pancreatic adenocarcinoma. J Gastrointest Surg Off J Soc Surg Aliment Tract 12:1068–1073. https://doi.org/10.1007/s11605-007-0422-6 CrossRef Ong SL, Garcea G, Thomasset SC, Mann CD, Neal CP, Abu Amara M, Dennison AR, Berry DP (2008) Surrogate markers of resectability in patients undergoing exploration of potentially resectable pancreatic adenocarcinoma. J Gastrointest Surg Off J Soc Surg Aliment Tract 12:1068–1073. https://​doi.​org/​10.​1007/​s11605-007-0422-6 CrossRef
17.
go back to reference Roberts KJ, Prasad P, Steele Y, Marcon F, Faulkner T, Cilliers H, Dasari B, Abradelo M, Marudanayagam R, Sutcliffe RP, Muiesan P, Mirza DF, Isaac J (2017) A reduced time to surgery within a “fast track” pathway for periampullary malignancy is associated with an increased rate of pancreatoduodenectomy. HPB 19:713–720. https://doi.org/10.1016/j.hpb.2017.04.011 CrossRefPubMed Roberts KJ, Prasad P, Steele Y, Marcon F, Faulkner T, Cilliers H, Dasari B, Abradelo M, Marudanayagam R, Sutcliffe RP, Muiesan P, Mirza DF, Isaac J (2017) A reduced time to surgery within a “fast track” pathway for periampullary malignancy is associated with an increased rate of pancreatoduodenectomy. HPB 19:713–720. https://​doi.​org/​10.​1016/​j.​hpb.​2017.​04.​011 CrossRefPubMed
18.
go back to reference van der Gaag NA, Rauws EAJ, van Eijck CHJ, Bruno MJ, van der Harst E, Kubben FJGM, Gerritsen JJGM, Greve JW, Gerhards MF, de Hingh IHJT, Klinkenbijl JH, Nio CY, de Castro SMM, Busch ORC, van Gulik TM, Bossuyt PMM, Gouma DJ (2010) Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med 362:129–137. https://doi.org/10.1056/NEJMoa0903230 CrossRefPubMed van der Gaag NA, Rauws EAJ, van Eijck CHJ, Bruno MJ, van der Harst E, Kubben FJGM, Gerritsen JJGM, Greve JW, Gerhards MF, de Hingh IHJT, Klinkenbijl JH, Nio CY, de Castro SMM, Busch ORC, van Gulik TM, Bossuyt PMM, Gouma DJ (2010) Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med 362:129–137. https://​doi.​org/​10.​1056/​NEJMoa0903230 CrossRefPubMed
28.
go back to reference Versteijne E, Vogel JA, Besselink MG, Busch ORC, Wilmink JW, Daams JG, van Eijck CHJ, Groot Koerkamp B, Rasch CRN, van Tienhoven G, the Dutch Pancreatic Cancer Group (2018) Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer. Br J Surg 105:946–958. https://doi.org/10.1002/bjs.10870 CrossRefPubMedPubMedCentral Versteijne E, Vogel JA, Besselink MG, Busch ORC, Wilmink JW, Daams JG, van Eijck CHJ, Groot Koerkamp B, Rasch CRN, van Tienhoven G, the Dutch Pancreatic Cancer Group (2018) Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer. Br J Surg 105:946–958. https://​doi.​org/​10.​1002/​bjs.​10870 CrossRefPubMedPubMedCentral
Metadata
Title
Effect of time to surgery in resectable pancreatic cancer: a systematic review and meta-analysis
Authors
Philip C. Müller
James Hodson
Christoph Kuemmerli
Marit Kalisvaart
Rupaly Pande
Keith J. Roberts
Publication date
01-05-2020
Publisher
Springer Berlin Heidelberg
Published in
Langenbeck's Archives of Surgery / Issue 3/2020
Print ISSN: 1435-2443
Electronic ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-020-01893-0

Other articles of this Issue 3/2020

Langenbeck's Archives of Surgery 3/2020 Go to the issue